Insider Transactions in Q3 2022 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 24
2022
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-10.91%
|
$375,000
$75.11 P/Share
|
|
Aug 24
2022
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.84%
|
$75,000
$15.01 P/Share
|
|
Aug 22
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
8,410
-2.2%
|
$588,700
$70.89 P/Share
|
|
Aug 22
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
8,410
+4.2%
|
$126,150
$15.01 P/Share
|
|
Aug 19
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
1,590
-0.86%
|
$111,300
$70.02 P/Share
|
|
Aug 19
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+0.85%
|
$23,850
$15.01 P/Share
|
|
Aug 16
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
20,000
-3.36%
|
$1,360,000
$68.72 P/Share
|
|
Aug 16
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.8%
|
$160,000
$8.44 P/Share
|
|
Aug 08
2022
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
10,000
-5.17%
|
$700,000
$70.07 P/Share
|
|
Aug 08
2022
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.54%
|
$50,000
$5.34 P/Share
|
|
Aug 05
2022
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
2,500
-11.73%
|
$162,500
$65.0 P/Share
|
|
Aug 04
2022
|
Christopher K. Murray CHIEF TECHNICAL OPERATIONS |
SELL
Open market or private sale
|
Direct |
2,500
-10.5%
|
$150,000
$60.44 P/Share
|